ADAPTHEALTH CORP. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.96 USD | +3.97% |
|
+6.64% | +36.63% |
| 04-17 | AdaptHealth Names Suzanne Foster as CEO | MT |
| 04-17 | AdaptHealth Names Suzanne Foster CEO | DJ |
Chart calendar AdaptHealth Corp.
3ee887a8e55daf5f8747ae1adf87.OxNO8E1tS1X2W-fupy0nRR6qXFeBmB47fGh-3QEHuPo.eFAnln8gfRzGI9G69Edidyv1ZDDV1GgMNjxTk20-4a5iIR-SNy8cG7QfjA~595db6b9bb2de3877c7f0311da051dc5
Upcoming events on AdaptHealth Corp.
Past events on AdaptHealth Corp.
| 12/03/2024 20:35 | Barclays Global Healthcare Conference |
| 11/03/2024 20:15 | Jefferies Value-Based Healthcare Summit - Fireside Chat |
| 27/02/2024 13:30 | Q4 2023 Earnings Call |
| 27/02/2024 12:00 | Q4 2023 Earnings Release |
| 11/01/2024 01:15 | JPMorgan Healthcare Conference |
| 05/12/2023 18:20 | BofA Home Care Conference - Fireside Chat |
| 28/11/2023 16:30 | Bank of America Securities Leveraged Finance Conference |
| 20/11/2023 13:00 | BTIG Digital Health Forum |
| 15/11/2023 17:40 | Stifel Healthcare Conference - Fireside Chat |
| 07/11/2023 13:30 | Q3 2023 Earnings Call |
| 07/11/2023 12:00 | Q3 2023 Earnings Release |
| 12/09/2023 14:40 | Baird Global Healthcare Conference |
| 09/08/2023 14:30 | Canaccord Genuity Growth Conference - Fireside Chat |
| 08/08/2023 13:30 | Q2 2023 Earnings Call |
| 08/08/2023 11:30 | Q2 2023 Earnings Release |
| 21/06/2023 15:30 | Annual General Meeting |
| 16/05/2023 21:05 | RBC Global Healthcare Conference |
| 09/05/2023 13:30 | Q1 2023 Earnings Call |
| 09/05/2023 12:35 | Q1 2023 Earnings Release |
| 28/02/2023 13:30 | Q4 2022 Earnings Call |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 530 522 1.4% | 1 056 1 031 2.46% | 2 455 2 439 0.62% | 2 971 2 979 -0.27% | 3 200 3 167 1.04% | 3 317 |
|
EBITDA Million USD | Released Forecast Spread | 123 122 0.93% | 206 190 8.14% | 566 575 -1.54% | 594 622 -4.51% | 671 636 5.5% | 682 |
|
EBIT Million USD | Released Forecast Spread | 60,5 50,9 18.89% | 123 91,7 34.37% | 308 293 5.02% | 243 274 -11.54% | 288 238 21.16% | 284 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -11,7 17,5 -167.19% | -70,7 21,5 -428.44% | 191 190 0.32% | 97,9 141 -30.75% | -724 -424 -70.66% | 144 |
|
Net income Million USD | Released Forecast Spread | -15,0 -10,4 -44.19% | -64,5 14,1 -556.46% | 156 151 3.69% | 69,3 112 -38.24% | -679 -405 -67.47% | 104 |
|
EPS USD | Released Forecast Spread | -0,66 -0,31 -112.9% | -1,23 0,24 -621.08% | 0,67 1,02 -34.13% | 0,33 0,73 -55% | -5,06 -3,15 -60.51% | 0,78 |
| Announcement Date | 25/02/20 | 04/03/21 | 24/02/22 | 27/02/23 | 27/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 702 690 1.77% | 706 651 8.4% | 728 724 0.46% | 756 738 2.51% | 780 788 -1% | 745 760 -2.05% | 793 765 3.67% | 804 797 0.93% | 858 825 3.97% | 770 | 821 | 839 | 887 | 819 |
|
EBITDA Million USD | Released Forecast Spread | 158 167 -5.31% | 138 131 5.2% | 150 151 -0.83% | 160 165 -3.05% | 146 178 -17.84% | 134 147 -8.78% | 171 150 13.82% | 161 172 -6.06% | 205 169 21.11% | 139 | 170 | 172 | 200 | 156 |
|
EBIT Million USD | Released Forecast Spread | 80,9 91,0 -11.11% | 60,6 63,6 -4.68% | 70,5 78,3 -9.94% | 67,8 81,4 -16.66% | 43,6 86,0 -49.26% | 40,2 50,9 -21.04% | 71,7 55,2 30.08% | 63,9 68,0 -6.03% | 112 68,9 62.92% | 42,6 | 69,8 | 71,6 | 101 | 59,4 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 33,5 56,3 -40.56% | 47,8 28,5 67.76% | 24,1 39,2 -38.51% | 22,8 53,7 -57.5% | 3,16 55,5 -94.31% | 15,0 18,9 -20.7% | 20,4 15,8 28.96% | -487 29,4 -1758.37% | -272 25,5 -1163.71% | 7,84 | 24,9 | 34,4 | 60,5 | |
|
Net income Million USD | Released Forecast Spread | 22,9 49,3 -53.46% | 41,8 22,2 87.97% | 14,0 32,5 -56.86% | 16,1 41,3 -60.96% | -2,59 38,2 -106.77% | 15,7 11,0 43.33% | 14,0 14,0 -0.52% | -454 24,6 -1944.51% | -255 23,4 -1186.46% | 5,35 | 24,8 | 25,0 | 49,1 | 16,1 |
|
EPS USD | Released Forecast Spread | 0,15 0,34 -55.99% | 0,08 0,14 -44.16% | 0,09 0,23 -61.6% | 0,11 0,29 -62.46% | -0,02 0,27 -107.29% | 0,12 0,07 62.47% | 0,09 0,10 -12.02% | -3,37 0,18 -1975.14% | -1,91 0,16 -1282.66% | 0,05 | 0,18 | 0,17 | 0,38 | 0,11 |
| Announcement Date | 24/02/22 | 10/05/22 | 09/08/22 | 08/11/22 | 27/02/23 | 09/05/23 | 08/08/23 | 07/11/23 | 27/02/24 | - | - | - | - | - |
More events
Past sector events for AdaptHealth Corp.
| 26/04/2024 | BLUE SAIL MEDICAL CO.,LTD.: Q1 2024 Earnings Release |
| 26/04/2024 | BLUE SAIL MEDICAL CO.,LTD.: Q4 2023 Earnings Release |
| 26/04/2024 11:00 | AVANTOR, INC.: Q1 2024 Earnings Release |
| 25/04/2024 | MOTIC (XIAMEN) ELECTRIC GROUP CO.,LTD: Q1 2024 Earnings Release |
| 25/04/2024 | MICRO-TECH (NANJING) CO.,LTD: Q1 2024 Earnings Release |
| 25/04/2024 | SINOCARE INC.: Q4 2023 Earnings Release |
| 25/04/2024 | JAFRON BIOMEDICAL CO.,LTD.: Q1 2024 Earnings Release |
| 25/04/2024 | MICRO-TECH (NANJING) CO.,LTD: Q4 2023 Earnings Release |
| 25/04/2024 | JAFRON BIOMEDICAL CO.,LTD.: Q4 2023 Earnings Release |
| 25/04/2024 | SINOCARE INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- AHCO Stock
- Calendar AdaptHealth Corp.
